Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
September 30, 2026 -63.82M
June 30, 2026 6.637M
March 31, 2026 51.25M
December 31, 2025 79.89M
September 30, 2025 -21.24M
June 30, 2025 -25.89M
March 31, 2025 -37.56M
December 31, 2024 -36.54M
September 30, 2024 -37.11M
June 30, 2024 -65.12M
March 31, 2024 -43.85M
December 31, 2023 -39.29M
September 30, 2023 -51.66M
June 30, 2023 -44.29M
March 31, 2023 -39.68M
December 31, 2022 -46.05M
September 30, 2022 -54.79M
June 30, 2022 -41.70M
March 31, 2022 -39.49M
December 31, 2021 -47.31M
September 30, 2021 -44.28M
June 30, 2021 -50.19M
March 31, 2021 -49.77M
December 31, 2020 -39.98M
September 30, 2020 -38.46M
Date Value
June 30, 2020 -33.29M
March 31, 2020 -29.03M
December 31, 2019 -29.22M
September 30, 2019 -16.46M
June 30, 2019 -14.45M
March 31, 2019 -24.34M
December 31, 2018 -23.53M
September 30, 2018 -39.47M
June 30, 2018 -33.70M
March 31, 2018 -30.05M
December 31, 2017 -16.55M
September 30, 2017 -7.482M
June 30, 2017 -14.36M
March 31, 2017 -15.09M
December 31, 2016 -19.63M
September 30, 2016 -13.96M
June 30, 2016 -12.61M
March 31, 2016 -20.54M
December 31, 2015 -19.83M
September 30, 2015 -19.92M
June 30, 2015 -16.68M
March 31, 2015 -18.67M
December 31, 2014 -20.71M
September 30, 2014 -18.33M
June 30, 2014 -17.99M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 6.451B
Aytu BioPharma, Inc. -3.881M
Daré Bioscience, Inc. -3.158M
Jaguar Health, Inc. -5.83M
Structure Therapeutics, Inc. -145.14M